Clinical Trial Update: Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating a chemoradiation regimen that combines cisplatin, fluorouracil (5-FU), and gefitinib (Iressa) with radiation therapy for locally adva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)
• Iressa (gefitinib)

Snippet

Sponsor: David Adelstein | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-03-01